Telehealth Prescribing of Stimulants for ADHD and Associated Risk for Later Stimulant and Substance Use Disorders
The results suggest that receipt of a stimulant prescription for ADHD via telehealth does not alter the risk for SUD, but receipt of an initial stimulant prescription via telehealth may signal increased risk of subsequent stimUD. The results, particularly for stimUD, require replication in other health care settings.
Authors
- Sean Esteban McCabe (ORCID: https://orcid.org/0000-0002-9622-4652)
- Timothy E. Wilens (ORCID: https://orcid.org/0000-0002-5749-8503)
- Amy M. Yule (ORCID: https://orcid.org/0000-0002-2409-9426)
- Vinod Rao (ORCID: https://orcid.org/0000-0002-2868-5000)
- Sylvia Lanni (ORCID: https://orcid.org/0000-0002-0409-7343)
- Philip Veliz (ORCID: https://orcid.org/0000-0003-2544-3468)
- Ty S. Schepis (ORCID: https://orcid.org/0000-0003-3655-0496)
Institutions
- Boston Medical Center (US)
- Institute for Women's Policy Research (US)
- Texas State University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- American Journal of Psychiatry
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1176/appi.ajp.20240346
- Citations
- 5
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 7.36